CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,552 | +162.1% | 1,415 | +114.1% | 0.00% | – |
Q2 2023 | $14,707 | -99.9% | 661 | -99.9% | 0.00% | -100.0% |
Q1 2023 | $11,253,583 | +20.9% | 519,556 | +13.3% | 0.05% | 0.0% |
Q4 2022 | $9,311,505 | +17.3% | 458,469 | +48.1% | 0.05% | -12.7% |
Q3 2022 | $7,938,000 | -8.1% | 309,605 | -14.8% | 0.06% | -14.1% |
Q2 2022 | $8,639,000 | +47.2% | 363,303 | +39.4% | 0.06% | +33.3% |
Q1 2022 | $5,869,000 | +18.9% | 260,610 | +4.6% | 0.05% | -5.9% |
Q4 2021 | $4,935,000 | +1447.0% | 249,260 | +1260.1% | 0.05% | +628.6% |
Q3 2020 | $319,000 | +17.7% | 18,327 | +13.7% | 0.01% | +40.0% |
Q2 2020 | $271,000 | +42.6% | 16,125 | +7.0% | 0.01% | +25.0% |
Q1 2020 | $190,000 | -47.2% | 15,067 | -49.4% | 0.00% | -75.0% |
Q4 2019 | $360,000 | -27.9% | 29,776 | -15.6% | 0.02% | +45.5% |
Q3 2019 | $499,000 | +15.8% | 35,269 | -8.7% | 0.01% | 0.0% |
Q2 2019 | $431,000 | -7.3% | 38,637 | -2.5% | 0.01% | -15.4% |
Q1 2019 | $465,000 | +42.6% | 39,623 | +62.5% | 0.01% | +18.2% |
Q4 2018 | $326,000 | +69.8% | 24,385 | +77.7% | 0.01% | +57.1% |
Q3 2018 | $192,000 | – | 13,719 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
S&T BANK/PA | 350,924 | $7,601 | 1.37% |
Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |